Integrating multi-omics summary data using a Mendelian randomization framework

Alzheimer's Disease Neuroimaging Initiative, Alzheimer's Disease Metabolomics Consortium

Research output: Contribution to journalArticlepeer-review

3 Scopus citations


Mendelian randomization is a versatile tool to identify the possible causal relationship between an omics biomarker and disease outcome using genetic variants as instrumental variables. A key theme is the prioritization of genes whose omics readouts can be used as predictors of the disease outcome through analyzing GWAS and QTL summary data. However, there is a dearth of study of the best practice in probing the effects of multiple -omics biomarkers annotated to the same gene of interest. To bridge this gap, we propose powerful combination tests that integrate multiple correlated P-values without assuming the dependence structure between the exposures. Our extensive simulation experiments demonstrate the superiority of our proposed approach compared with existing methods that are adapted to the setting of our interest. The top hits of the analyses ofmulti-omics Alzheimer's disease datasets include genes ABCA7 and ATP1B1.

Original languageEnglish (US)
Article numberbbac376
JournalBriefings in Bioinformatics
Issue number6
StatePublished - Nov 1 2022
Externally publishedYes

All Science Journal Classification (ASJC) codes

  • Information Systems
  • Molecular Biology


  • GWAS
  • Mendelian randomization
  • P-value combination
  • QTL
  • multi-omics data


Dive into the research topics of 'Integrating multi-omics summary data using a Mendelian randomization framework'. Together they form a unique fingerprint.

Cite this